With blockbuster GLP-1 drugs such as Ozempic, Wegovy from Danish drug maker Novo Nordisk, and Mounjaro from American pharma ...

China's declining market share is one of the main drivers of India's CDMO industry expansion, highlighted the brokerage report. China became the world's top CDMO player by providing generous ...

The Global Advanced Drug Delivery CDMO Market is expected to witness a healthy and a double-digit growth rate by 2027. Major advantages offered by advanced drug delivery systems such as targeted and ...

Browse 270 market data Tables and 56 Figures spread through 254 Pages and in-depth TOC on "Oligonucleotide CDMO Market by Service (Contract Manufacturing (Clinical, Commercial), Development), Type ...

The reliance on specific regions, such as China and India ... can capture a larger share of this high-value market segment. Future Outlook of the Small Molecule CMO/CDMO Market The future of ...

The therapeutics segment holds the largest market share, driven by the increasing prevalence of chronic diseases. The demand for recombinant protein therapeutics is particularly high in oncology, ...

The Global Pharmaceutical CDMO (Contract Development and Manufacturing Organization) Market was valued at approximately USD 136.94 billion in 2022 and is expected to ...

While India has the cost advantage, China has long dominated ... way for India to capture a significant share of the expansion of the global CDMO market. According to a global market report ...

DUBLIN--(BUSINESS WIRE)--The "Semi-Solid Dosage CDMO Market Size, Share & Trends Analysis Report By Route of Administration (Topical, Transdermal), By Product, By Service, By End Use, By Region ...